AR001858A1 - Una composición de agente diagnostica o terapéuticamente efectiva - Google Patents

Una composición de agente diagnostica o terapéuticamente efectiva

Info

Publication number
AR001858A1
AR001858A1 AR33640796A AR33640796A AR001858A1 AR 001858 A1 AR001858 A1 AR 001858A1 AR 33640796 A AR33640796 A AR 33640796A AR 33640796 A AR33640796 A AR 33640796A AR 001858 A1 AR001858 A1 AR 001858A1
Authority
AR
Argentina
Prior art keywords
therapeutically effective
agent composition
diagnostic agent
macromolecular structures
well
Prior art date
Application number
AR33640796A
Other languages
English (en)
Original Assignee
Polymasc Pharmaceuticals Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymasc Pharmaceuticals Plc filed Critical Polymasc Pharmaceuticals Plc
Publication of AR001858A1 publication Critical patent/AR001858A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La administración de agentes de diagnóstico y terapéuticos a la piel o a tumores sólidos es perfeccionada mediante la optimización de las estructurasmacromoleculares que contienen lípidos (por ejemplo liposomas) que encapsulan los agentes y elt ipo y cantidad de porciones hidrofílicas unidas al exteriorde las estructuras macromoleculares, así como también las proporciones relativas de los varios lípidos, u otras entidades hidrófobas que forman lasestructuras macromoleculares.
AR33640796A 1995-05-03 1996-05-03 Una composición de agente diagnostica o terapéuticamente efectiva AR001858A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509016.3A GB9509016D0 (en) 1995-05-03 1995-05-03 Tissue entrapment

Publications (1)

Publication Number Publication Date
AR001858A1 true AR001858A1 (es) 1997-12-10

Family

ID=10773939

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33640796A AR001858A1 (es) 1995-05-03 1996-05-03 Una composición de agente diagnostica o terapéuticamente efectiva

Country Status (7)

Country Link
EP (1) EP0825850A1 (es)
JP (1) JPH11504915A (es)
AR (1) AR001858A1 (es)
AU (1) AU5509796A (es)
CA (1) CA2218932A1 (es)
GB (1) GB9509016D0 (es)
WO (1) WO1996034598A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645463B1 (en) 1994-05-16 2003-11-11 The Board Of Regents Of The University Of Michigan Blood-pool selective carrier for lipophilic imaging agents
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
US6673364B1 (en) 1995-06-07 2004-01-06 The University Of British Columbia Liposome having an exchangeable component
CA2286138A1 (en) * 1997-04-11 1998-10-22 Marc A. Longino Blood-pool carrier for lipophilic imaging agents
US6734171B1 (en) 1997-10-10 2004-05-11 Inex Pharmaceuticals Corp. Methods for encapsulating nucleic acids in lipid bilayers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720857B2 (ja) * 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
GB8824593D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Liposomes
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
DE69107844T2 (de) * 1990-04-18 1995-08-10 Takeda Chemical Industries, Ltd., Osaka Liposomenzusammensetzung.
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
US6326353B1 (en) * 1993-03-23 2001-12-04 Sequus Pharmaceuticals, Inc. Enhanced circulation effector composition and method

Also Published As

Publication number Publication date
GB9509016D0 (en) 1995-06-21
CA2218932A1 (en) 1996-11-07
JPH11504915A (ja) 1999-05-11
AU5509796A (en) 1996-11-21
WO1996034598A1 (en) 1996-11-07
EP0825850A1 (en) 1998-03-04

Similar Documents

Publication Publication Date Title
PT733357E (pt) Formulacoes farmaceuticas na forma de gel tixotropico
ES2035847T3 (es) Un procedimiento para la elaboracion de una preparacion farmaceutica.
ES2140847T3 (es) Procedimientos y formulaciones para modular la respuesta sexual humana.
LV10180A (lv) Farmaceitiska kompozicija
ES2038632T3 (es) Una preparacion para curar heridas y su procedimiento de elaboracion.
ES2134776T3 (es) Microcristales recubiertos con fosfolipidos: formulaciones inyectables de medicamentos insolubles en agua.
ES2171971T3 (es) Producto limpiador y de tratamiento con almidon.
ATE51522T1 (de) Formulierung nicht irritierender ophthalmischer waesseriger zusammensetzungen fuer okulartherapeutische mittel.
ES2170259T3 (es) Empleo de lipidos como agentes auxiliares en la obtencion de formas farmaceuticas solidas segun el procedimiento de extrusion en fusion.
PT782448E (pt) Formulacoes oticas antibacterianas nao ototoxicas nao sensibilizantes nao irritantes
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
BR9809117A (pt) Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada
RU95103892A (ru) Композиция топического нанесения для стимулирования роста волос и/или замедления их выпадения, способ косметического лечения волос, применение производного альфа -пирона для получения композиции
AR001858A1 (es) Una composición de agente diagnostica o terapéuticamente efectiva
CO4700420A1 (es) Formulacion transdermica
BR9910024A (pt) Agente contra resfriado
ES2093102T3 (es) Metodo que permite reducir las propiedades irritantes de una composicion cosmetica.
FR2686513B1 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
BR0009194A (pt) Composição do resorcinol
DE69532819D1 (de) Kohlenhydrate derivate und die enthaltende zusammensetzungen
CA2264094A1 (en) Structured water for enhanced moisturization
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
ES2040240T3 (es) Agente citostatico de platino.

Legal Events

Date Code Title Description
FB Suspension of granting procedure